Skip to main content

Keystone Financial Group

SEC CIK
0001729299
Latest filing
Jul 29, 2026

IBRX holding history

ImmunityBio, Inc. in every 13F filed by Keystone Financial Group, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

IBRX overviewAll 13F holders of IBRXFull Q2 2026 holdings

Shares (Q2 2026)
10,000
Value
$87.5K
% of portfolio
<0.1%
Quarters held
4
Since Q2 2025
Holdings of IBRX by Keystone Financial Group, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202610,000$87.5K<0.1%00.0%UnchangedHolders
Q1 202610,000$76.7K<0.1%00.0%UnchangedHolders
Q4 202510,000$19.8K<0.1%+10,000NewHolders
Q3 20250$00.0%−10,000−100.0%Sold outHolders
Q2 202510,000$26.4K<0.1%+10,000NewHolders